No substantial effect of increased risk of ovarian cancer was seen in the respective ovarian cluster regions of each gene and only a borderline significant reduction of breast cancer risk was seen for BRCA2. Much of the OCCR association has been based on ratios of breast to ovarian cancer [10] or on the presence or not of ovarian cancer in the family [11]. This evidence concerns the gene BRCA2 and breast cancer.